The House Concurrent Resolution No. by Representative Turner calls on the United States Congress to take action against the detrimental practices of pharmacy benefit managers (PBMs), which significantly influence the pricing and accessibility of prescription medications. PBMs, acting as intermediaries for health insurers and government programs, have been criticized for contributing to rising drug costs, lack of transparency, and restrictive formularies that limit patient access to necessary medications. The resolution highlights the adverse effects of these practices on vulnerable populations, including seniors and low-income families, and emphasizes Louisiana's commitment to improving healthcare access for its residents.

The resolution urges Congress to implement measures that would increase transparency in PBM operations, ensure that savings from negotiated drug prices are passed on to consumers, and regulate PBM practices to prevent anti-competitive behavior. It also calls for enhanced oversight of PBMs to protect consumers, particularly those in underserved communities, and advocates for accountability measures for any harm caused to patients. The Louisiana Legislature requests that its congressional delegation actively support and promote legislation aimed at reforming PBM practices to safeguard the interests of the state's citizens and improve overall healthcare delivery.